To begin to explore the mechanism of action of this cell‐surface receptor, we took advantage of our earlier model system, Siglec‐XII nonexpressing PC‐3 prostate carcinoma cells, which were transfected with a vector causing expression of full‐length Siglec‐XII. The gene discussed is SIGLEC12; the disease is prostate carcinoma.